Table of Contents
Chapter 1. Executive Overview of the Space
- Scope of this Market Report
- Challenges in the Cellular Therapy Space
- Cardiovascular Disease Market Segmentation
- Cardiovascular Disease Market Opportunity
- Embryonic Stem Cell (ESC) Differentiation into Multiple Cellular
Chapter 2. Mesenchymal Stem Cells (MSCs) for Regenerative Medicine
- MSCs: Definition and Properties
- MSC Phenotype
- Heart Cell Lineage Diversification
- Pericytes: Tissue-Specific Progenitors
- Mechanisms of MSC-mediated Tissue Repair
- Fetal versus Adult MSCs
Chapter 3. Stem Cells for Cardiovascular Disease: Technology Landscape, Market Landscape, Clinical Trials Landscape
- Cellular Therapy for Cardiovascular Diseases
- Proposed Mechanisms of MSC-mediated Cardiovascular Repair
- Potential Delivery Routes of MSC-based Cellular Therapy for Cardiovascular
Diseases
- Safety Concerns with Stem Cell Therapy for Cardiovascular Disease
- Quantitative Market Analysis of the Cardiovascular Regenerative Medicine
Space
- Stem Cells for Cardiovascular Disease: Clinical Trials Landscape
Chapter 4. Stem Cells for Cardiovascular Disease: Selected Industry Events and Companies in the Space
- Selected Industry Events in Cardiovascular Cellular Therapy Sapce
- Profiles of Companies in the Cardiovascular Cellular Therapy Space
Appendix 1. Research Methodology
Appendix 2. Stem Cells for Cardiovascular Disease: Worldwide Clinical Trials Details
Appendix 3. Cardiovascular Disease Patient Population Statisstics
|
Related Report
|
View Cart
